Mobia Medical's Implant Recognized in Guidelines for Adult Stroke Rehabilitation
MT Newswires Live
Aug 28
Mobia Medical's (MOBI) implantable paired Vagus Nerve Stimulation has been recognized in the 2026 Guideline for Adult Stroke Rehabilitation and Recovery by the American Heart Association and American Stroke Association, the medical device company said Friday.
The new guideline indicates that Vagus Nerve Stimulation, when paired with high-dose task-specific training, may be considered to improve upper-limb function and impairment for eligible patients, Mobia said.
"Recognition of paired [Vagus Nerve Stimulation] in the guideline for stroke recovery is a meaningful validation" of Mobia's technology, the company quoted its chief executive officer, Richard Foust, as saying.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.